Medical Imaging 2023: Image Perception, Observer Performance, and Technology Assessment 2023
DOI: 10.1117/12.2654344
|View full text |Cite
|
Sign up to set email alerts
|

Predictive adjudication rate modeling for prioritizing case distribution in BICR for oncology clinical trials

Abstract: Blinded independent central review is recommended by the US FDA for registration of oncology trials as it provides bias-free image assessment and avoidance of potential unblinding of patient data. Double read with adjudication is a highly advocated review model used in such trials. Disagreement between readers is natural and inevitable. Radiological disagreement rates or Adjudication Rate (AR) of 30–65% are reported by several papers since 1959 for different oncologic indications. The aim of the study is to de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 5 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?